Non-Hodgkin's Lymphoma
3 competing products in clinical development for Non-Hodgkin's Lymphoma.
Pipeline by Phase
Phase 11
Phase 22
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| YM155 + Rituximab | Astellas Pharma | Phase 2 | Completed | 35 |
| ONTAK | Eisai | Phase 2 | Completed | 35 |
| Tirabrutinib | Ono Pharmaceutical | Phase 1 | Completed | 29 |